AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (810.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response

Lipeng Qiua( ), Yue Wanga, Zhihuan Lia, Zhigang Tua( ), Hanqing Liub( )
School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China
School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 363-365

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Qiu L, Wang Y, Li Z, et al. The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response. Genes & Diseases, 2023, 10(2): 363-365. https://doi.org/10.1016/j.gendis.2022.04.010

827

Views

11

Downloads

2

Crossref

2

Web of Science

2

Scopus

0

CSCD

Received: 05 November 2021
Published: 30 April 2022
© 2022 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).